FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
On Wednesday, the U.S. Food and Drug Administration announced the approval of the first respiratory syncytial virus (RSV) vaccine for use in the United States. Arexvy, manufactured by GlaxoSmithKline Biologicals,…